Skip to main content

EVOLUCION DIRIGIDA DE VIRUS ONCOLITICOS

BFU2017-84762-R

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos I+D+i Retos de Investigación
Call year 2017
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Directed evolution of a Mycobacteriophage

  • Cebriá-Mendoza, María
  • Sanjuán, Rafael
  • Domingo-Calap, Pilar
This article belongs to the Special Issue Bacteriophages: Alternatives to Antibiotics and Beyond., Bacteriophages represent an alternative strategy to combat pathogenic bacteria. Currently, Mycobacterium tuberculosis infections constitute a major public health problem due to extensive antibiotic resistance in some strains. Using a non-pathogenic species of the same genus as an experimental model, Mycobacterium smegmatis, here we have set up a basic methodology for mycobacteriophage growth and we have explored directed evolution as a tool for increasing phage infectivity and lytic activity. We demonstrate mycobacteriophage adaptation to its host under different conditions. Directed evolution could be used for the development of future phage therapy applications against mycobacteria., This work was funded by grant BFU2017-84762-R from the Spanish Ministerio de Ciencia, Innovación y Universidades (MCIU) and grant 724519-Vis-à-vis from the European Research Council (ERC) to R.S. P.D.-C. was recipient of a Juan de la Cierva Incorporación contract from MCIU., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cooperative nature of viral replication

  • Andreu-Moreno, Iván
  • Bou, Juan-Vicente
  • Sanjuán, Rafael
The ability of viruses to infect their hosts depends on rapid dissemination following transmission. The notion that viral particles function as independent propagules has been challenged by recent observations suggesting that viral aggregates show enhanced infectivity and faster spread. However, these observations remain poorly understood. Here, we show that viral replication is a cooperative process, such that entry of multiple viral genome copies into the same cell disproportionately increases short-term viral progeny production. This cooperativity arises from the positive feedback established between replication templates and virus-encoded products involved in replication and should be a general feature of viruses. We develop a simple model that captures this effect, verify that cooperativity also emerges in more complex models for specific human viruses, validate our predictions experimentally using different mammalian viruses, and discuss the implications of cooperative replication for viral fitness., This work was funded by ERC Consolidator Grant 724519 (Vis-a-Vis) and the Spanish Ministerio de Ciencia, Innovación y Universidades (grant BFU2017-84762-R). I.A.-M. was funded by a Ph.D. fellowship from the Spanish Ministerio de Ciencia, Innovación y Universidades. J.-V.B. was funded by Prometeo Grant 2016/122 from the Generalitat Valenciana. A, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Experimental virus evolution in cancer cell monolayers, spheroids, and tissue explants

  • Al-Zaher, Ahmed
  • Domingo-Calap, Pilar
  • Sanjuán, Rafael
Viral laboratory evolution has been used for different applications, such as modeling viral emergence, drug-resistance prediction, and therapeutic virus optimization. However, these studies have been mainly performed in cell monolayers, a highly simplified environment, raising concerns about their applicability and relevance. To address this, we compared the evolution of a model virus in monolayers, spheroids, and tissue explants. We performed this analysis in the context of cancer virotherapy by performing serial transfers of an oncolytic vesicular stomatitis virus (VSV-Δ51) in 4T1 mouse mammary tumor cells. We found that VSV-Δ51 gained fitness in each of these three culture systems, and that adaptation to the more complex environments (spheroids or explants) correlated with increased fitness in monolayers. Most evolved lines improved their ability to suppress β-interferon secretion compared to the VSV-Δ51 founder, suggesting that the selective pressure exerted by antiviral innate immunity was important in the three systems. However, system-specific patterns were also found. First, viruses evolved in monolayers remained more oncoselective that those evolved in spheroids, since the latter showed concomitant adaptation to non-tumoral mouse cells. Second, deep sequencing indicated that viral populations evolved in monolayers or explants tended to be more genetically diverse than those evolved in spheroids. Finally, we found highly variable outcomes among independent evolutionary lines propagated in explants. We conclude that experimental evolution in monolayers tends to be more reproducible than in spheroids or explants, and better preserves oncoselectivity. Our results also suggest that monolayers capture at least some relevant selective pressures present in more complex systems., This work was supported by grant BFU2017-84762 from the Ministerio de Ciencia e Innovación to R.S. and by a Juan de Cierva Incorporación contract to P.D-C., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Cellular resistance to an oncolytic virus is driven by chronic activation of innate immunity

  • Larrieux, Alejandra
  • Sanjuán, Rafael
The emergence of cellular resistances to oncolytic viruses is an underexplored process that could compromise the efficacy of cancer virotherapy. Here, we isolated and characterized B16 mouse melanoma cells that evolved resistance to an oncolytic vesicular stomatitis virus (VSV-D51). RNA-seq revealed that resistance was associated to broad changes in gene expression, which typically involved chronic upregulation of interferon-stimulated genes. Innate immunity activation was maintained in the absence of the virus or other infection signals, and conferred cross-resistance to wild-type VSV and the unrelated Sindbis virus. Furthermore, we identified differentially expressed genes with no obvious role in antiviral immunity, such as Mnda, Psmb8 and Btn2a2, suggesting novel functions for these genes. Transcriptomic changes associated to VSV resistance were similar among B16 clones and in some clones derived from the mouse colon carcinoma cell line CT26, suggesting that oncolytic virus resistance involves certain conserved mechanisms and is therefore a potentially predictable process., This work was supported by grant BFU2017-84762 from the Ministerio de Ciencia e Innovación to R.S., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Five Challenges in the Field of Viral Diversity and Evolution

  • Sanjuán, Rafael
  • Illingworth, Christopher
  • Geoghegan, Jemma
  • Iranzo, Jaime
  • Zwart, Mark P.
  • Ciota, Alexander
  • Moratorio, Gonzalo
  • Gago-Zachert, Selma
  • Duffy, Siobain
  • Vijaykrishna, Dhanasekaran
Viral diversity and evolution play a central role in processes such as disease emergence, vaccine failure, drug resistance, and virulence. However, significant challenges remain to better understand and manage these processes. Here, we discuss five of these challenges. These include improving our ability to predict viral evolution, developing more relevant experimental evolutionary systems, integrating viral dynamics and evolution at different scales, systematic appraisal of the virosphere, and deepening our understanding of virus-virus interactions. Intensifying future research on these areas should improve our ability to combat viral diseases, as well as to exploit viral diversity and evolution for biotechnological purposes., This work was funded by the European Research Council (CoG 724519 Vis-a-Vis), the Spanish Ministerio de Ciencia e Innovación (BFU2017-84762-R, RYC-2017-22524, PID2019-106618GA-I00, and SEV-2016-0672), the UK Medical Research Council (MC_UU_00002/11), the New Zealand Royal Society Rutherford Discovery Fellowship (RDF-20-UOO-007), the US National Institutes of Health (R21AI13168302 and R21AI14685602), the Agencia Nacional de Investigación e Innovación de Uruguay (FCE120191156157 and FCE120191155930), DARPA PREEMPT (#HR001118S0017-PREEMPT-FP001), the G4 Research Program from the Institut Pasteur of Montevideo, and the US National Institute of Allergy and Infectious Diseases (CEIRS contract 546HHSN272201400006C)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Genome-scale analysis of evolutionary rate and selection in a fast-expanding Spanish cluster of HIV-1 subtype F1

  • Patiño-Galindo, Juan Á.
  • Domínguez, Francisco
  • Cuevas, María T.
  • Delgado, Clara Elena
  • Sánchez, Mónica
  • Pérez-Alvárez, Lucía
  • Thomson, Michael M.
  • Sanjuán, Rafael
  • González-Candelas, Fernando
  • Cuevas, José M.
PMCID: PMC6978151, This work is aimed at assessing the presence of positive selection and/or shifts of the evolutionary rate in a fast-expanding HIV-1 subtype F1 transmission cluster affecting men who have sex with men in Spain. We applied Bayesian coalescent phylogenetics and selection analyses to 23 full-coding region sequences from patients belonging to that cluster, along with other 19 F1 epidemiologically-unrelated sequences. A shift in the overall evolutionary rate of the virus, explained by positively selected sites in the cluster, was detected. We also found one substitution in Nef (H89F) that was specific to the cluster and experienced positive selection. These results suggest that fast transmission could have been facilitated by some inherent genetic properties of this HIV-1 variant., This work was supported by the Spanish AIDS Research Network, funded by the Instituto de Salud Carlos III, Spanish Health Ministry (Grant n° RD12/0017/0033 to RS). JMC was funded by a Ramón y Cajal contract and the MICIU (project SAF2017-82287-R). RS and FGC were funded by Generalitat Valenciana (project PROMETEO/2016/122). FGC was funded by Spanish MINECO (projects BFU2014-58656-R and BFU2017-89594-R). RS was funded by MINECO (project BFU2017-84762-R) and the European Research Council (grant 724519-Vis-à-vis). MMT and ED are funded by Instituto de Salud Carlos III through Acción Estratégica en Salud Intramural (AESI) (project PI16CIII/00033) and Red de Investigación en SIDA (RIS) (project RD16ISCIII/0002/000C)., Peer reviewed